Germany import price index rose 4.3% month-on-month may have an impact on the polymerase chain reaction test price

The German import price index rose 4.3 percent month-on-month and 32.7 percent year-on-year in August 2022 due to energy shortages, the largest year-on-year increase since March 1974, data from the German Federal Statistical Office showed on October 7 local time.

Data showed that Germany's energy import prices rose 18.9 percent month-on-month in August and 162.4 percent year-on-year. Among them, Germany's gas import prices in August rose 48.2% month on month and 306.3% year on year. High energy prices also boosted export prices, with Germany's export price index rising 2.1 percent month-on-month and 18.6 percent year-on-year in August, data showed.

Meanwhile, German industrial output fell month-on-month in August, following a 0.3 percent fall in July. Germany's industrial output, adjusted for prices, seasons, and working days, fell 0.8 percent in August from the previous month, the Federal Statistics Office said Monday.

High uncertainty over the ongoing conflict between Russia and Ukraine and a sharp reduction in gas supplies from Russia have dampened industrial activity in Germany, the Federal Ministry of Economy and Climate Protection said in a statement on Monday. The outlook for Germany's industrial economy in the coming months is bleak given the decline in new orders and the chill in business sentiment.

Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables or polymerase chain reaction test . Welcome to contact GENETURE or Send an email to: info@geneture.com and our professional sales engineer will get back to you within 48 hours.

Analysis and forecast of the market size of PCR diagnostic industry

Polymerase chain reaction (PCR) is a nucleic acid synthesis technology that uses the principle of DNA double-strand replication to replicate specific DNA fragments in vitro. With this technology, the detection equipment can amplify the target gene in a large number in a short time, expanding the target gene fragment to the order of millions to billions, thus achieving high sensitivity detection. At present, polymerase chain reaction (PCR) diagnosis of infectious diseases such as hepatitis, venereal disease, intestinal respiratory disease and tumor single gene detection is an important application field. In 2020, polymerase chain reaction (PCR) diagnostic technology was identified as the "gold standard" for COVID-19 diagnosis due to its high sensitivity and accuracy.

China's PCR diagnostic market is developing rapidly, with the market size growing rapidly from about RMB 2.37 billion in 2015 to about RMB 5.93 billion in 2019, with a compound annual growth rate of 25.8%. China's PCR industry experienced explosive growth due to the huge demand for testing caused by the outbreak of COVID-19 in 2020, and the market size of China's PCR diagnostic industry exceeded 10 billion yuan in 2020. With the introduction of a large number of PCR diagnostic instruments, the PCR diagnostic industry will enter a new stage of development. It is expected that the PCR diagnostic industry will maintain a double-digit growth rate, and the market size of the PCR diagnostic industry will reach about 23.42 billion yuan in 2030 based on the factory price, and the cagR will reach about 13.3% from 2019 to 2030.

Market Demand of the polymerase chain reaction test

The DNA/RNA Extraction Kit market and other polymerase chain reaction test s are projected to grow at a CAGR of 8.26% during the forecast period 2022-2027.

The COVID-19 pandemic has impacted the polymerase chain reaction test market for a short time due to restrictions on different business and research activities for polymerase chain reaction test s. In addition, diagnostic tests for other diseases and medical conditions in hospitals and other clinical diagnostic facilities have been affected as COVID-19 has led to fewer patients taking tests. However, the high rate of COVID-19 infection and research activities are undertaken by major companies in the field of sequencing to expand their understanding of the virus and its origins, as well as molecular diagnostics of the SARS-COV-2 virus, have led to the development and launch of many DNA - and RNA-BASED COVID-19 kits, The kits proved so important that they were in great demand.

Market drivers for the polymerase chain reaction test

The growth of the DNA/RNA extraction kit market is primarily driven by increased investment in R&D activities in different areas, including molecular diagnostics for different chronic and infectious diseases. For example, the US spent $842 billion on R&D activities in 2020, followed by China at $664 billion, according to the ORGANISATION for Economic Co-operation and Development. Technological advances worldwide, new product launches by major market players, and an increase in cancer cases are also likely to complement the growth of the markets under study.

Other factors, such as increased demand for automation of DNA/RNA extraction technologies, new user-friendly and easy extraction kits, and DNA/RNA for analysis of new diseases causing microorganisms, are expected to drive DNA/RNA growth. RNA Extraction Kit market during the forecast period. Therefore, low awareness and availability of the kit and low market penetration in less developed and developing regions around the world are the major factors limiting the growth of the DNA/RNA extraction kit market.

North America is expected to dominate the global polymerase chain reaction test market during the forecast period

North America, which holds a major share in the polymerase chain reaction test market, is expected to show a similar trend during the forecast period, mainly due to the high level of R&D activity in the region and the presence of major market players in the region constantly developing their products for the markets studied.

In the region, the US is expected to take a major share of the DNA/RNA extraction kit market due to heavy investment in R&D by government and private entities, increased demand for polymerase chain reaction test s, and the rising prevalence of chronic diseases.

The polymerase chain reaction test professional supplier manufacturer -Geneture

Geneture is a professional supplier of Nucleic Acid Extraction Reagent,Automatic Nucleic Acid Extraction,Lab consumables, Real-time PCR, Covid-19 Rapid Test Supplier. Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables.

Feel free to get a qutoe send an email to: info@geneture.com and our professional sales engineer will get back to you within 48 hours.

Inquiry us